CNTN
MaterialsTharimmune Inc
Live · NASDAQ · May 9, Close
What's Moving CNTN Today?
No stock-specific AI insight has been generated for CNTN yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
CNTN News
3 articles- Tharimmune Highlights Canton Network Q1 Growth, Tokenomics Shift and Validator Locking in WebinarMarketbeat·Apr 26, 2026
- Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem UpdateYahoo Finance·Apr 20, 2026
- Crypto Currents: SEC, CFTC sign MOU for Joint Harmonization InitiativeYahoo Finance·Mar 14, 2026
All 3 articles loaded
Price Data
Fundamentals
Trading
About Tharimmune Inc
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.